If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Stefania Villa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Derivatives Chemical Compounds
Octanes Medicine & Life Sciences
Congo Red Medicine & Life Sciences
Oxadiazoles Chemical Compounds
STAT3 Transcription Factor Medicine & Life Sciences
Opioid Receptors Medicine & Life Sciences
hydrazine Chemical Compounds
Antitubercular Agents Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

Human Red Blood Cells as Oxygen Carriers to Improve Ex-Situ Liver Perfusion in a Rat Model

Dondossola, D., Santini, A., Lonati, C., Zanella, A., Merighi, R., Vivona, L., Battistin, M., Galli, A., Biancolilli, O., Maggioni, M., Villa, S. & Gatti, S., Nov 8 2019, In : Journal of Clinical Medicine. 8, 11, E1918.

Research output: Contribution to journalArticle

Eagles
Perfusion
Erythrocytes
Oxygen
Liver

New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents

Chiarelli, L. R., Mori, M., Beretta, G., Gelain, A., Pini, E., Sammartino, J. C., Stelitano, G., Barlocco, D., Costantino, L., Lapillo, M., Poli, G., Caligiuri, I., Rizzolio, F., Bellinzoni, M., Tuccinardi, T., Villa, S. & Meneghetti, F., Jan 1 2019, In : Journal of Enzyme Inhibition and Medicinal Chemistry. 34, 1, p. 823-828 6 p.

Research output: Contribution to journalArticle

Open Access
Antitubercular Agents
Salicylates
Disclosure
furan
Lead

New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents

Chiarelli, L. R., Mori, M., Beretta, G., Gelain, A., Pini, E., Sammartino, J. C., Stelitano, G., Barlocco, D., Costantino, L., Lapillo, M., Poli, G., Caligiuri, I., Rizzolio, F., Bellinzoni, M., Tuccinardi, T., Villa, S. & Meneghetti, F., Jan 1 2019, In : Journal of Enzyme Inhibition and Medicinal Chemistry. 34, 1, p. 823-828 6 p.

Research output: Contribution to journalArticle

Open Access
Antitubercular Agents
Salicylates
Disclosure
furan
Lead

Evaluation of mediators associated with the inflammatory response in prostate cancer patients undergoing radiotherapy

Bedini, N., Cicchetti, A., Palorini, F., Magnani, T., Zuco, V., Pennati, M., Campi, E., Allavena, P., Pesce, S., Villa, S., Avuzzi, B., Morlino, S., Visentin, M. E., Zaffaroni, N., Rancati, T. & Valdagni, R., 2018, In : Disease Markers. 2018

Research output: Contribution to journalArticle

New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies

Pini, E., Poli, G., Tuccinardi, T., Chiarelli, L. R., Mori, M., Gelain, A., Costantino, L., Villa, S., Meneghetti, F. & Barlocco, D., Jun 21 2018, In : Molecules. 23, 7

Research output: Contribution to journalArticle

Molecular modeling
Salicylates
Iron Chelating Agents
Antitubercular Agents
Lead compounds